1. |
Kim HJ, Park JS. Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Dev Reprod, 2017, 21(1): 1-10.
|
2. |
Wang Y, Huso DL, Harrington J, et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy, 2005, 7(6): 509-519.
|
3. |
Røsland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res, 2009, 69(13): 5331-5339.
|
4. |
Rubio D, Garcia-Castro J, Martin MC, et al. Spontaneous human adult stem cell transformation. Cancer Res, 2005, 65(8): 3035-3039.
|
5. |
Serakinci N, Guldberg P, Burns JS, et al. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene, 2004, 23(29): 5095-5098.
|
6. |
Miura M, Miura Y, Padilla-Nash HM, et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells, 2006, 24(4): 1095-1103.
|
7. |
Zhou YF, Bosch-Marce M, Okuyama H, et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res, 2006, 66(22): 10849-10854.
|
8. |
Li H, Fan X, Kovi RC, et al. Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: a model of age-related tumorigenesis in mice. Cancer Res, 2007, 67(22): 10889-10898.
|
9. |
Tolar J, Nauta AJ, Osborn MJ, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells, 2007, 25(2): 371-379.
|
10. |
Berman SD, Calo E, Landman AS, et al. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A, 2008, 105(33): 11851-11856.
|
11. |
Mohseny AB, Szuhai K, Romeo S, et al. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2. J Pathol, 2009, 219(3): 294-305.
|
12. |
Gambera S, Abarrategi A, Rodríguez-Milla MA, et al. Role of AP-1 complex in phenotype of human osteosarcomas generated from mesenchymal stem cells. Stem Cells, 2018. [Epub ahead of print].
|
13. |
Zhao Y, Chen J, Dai X, et al. Human glioma stem-like cells induce malignant transformation of bone marrow mesenchymal stem cells by activating TERT expression. Oncotarget, 2017, 8(61): 104418-104429.
|
14. |
Kim M, Rhee JK, Choi H, et al. Passage-dependent accumulation of somatic mutations in mesenchymal stromal cells during in vitro culture revealed by whole genome sequencing. Sci Rep, 2017, 7(1): 14508.
|
15. |
Xin X, Wang C, Lin Z, et al. Inflammatory-related P62 triggers malignant transformation of mesenchymal stem cells through the cascade of CUDR-CTCF-IGFⅡ-RAS signaling. Mol Ther Nucleic Acids, 2018, 11: 367-381.
|
16. |
Rubio D, Garcia S, Paz MF, et al. Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS One, 2008, 3(1): e1398.
|
17. |
Jiang T, Liu J, Ouyang Y, et al. Intra-hydrogel culture prevents transformation of mesenchymal stem cells induced by monolayer expansion. Biomater Sci, 2018, 6(5) :1168-1176.
|
18. |
高芸, 单忠艳, 滕卫平, 等. 自发恶性转化的大鼠骨髓间充质干细胞基因表达谱的芯片分析. 现代肿瘤医学, 2009, 17(4): 595-598.
|
19. |
Teng IW, Hou PC, Lee KD, et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res, 2011, 71(13): 4653-4663.
|
20. |
Choi MR, In YH, Park J, et al. Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med, 2012, 44(8): 503-512.
|